No abstract available
MeSH terms
-
Adult
-
Antifungal Agents / therapeutic use
-
Antineoplastic Combined Chemotherapy Protocols / administration & dosage
-
Antineoplastic Combined Chemotherapy Protocols / adverse effects
-
Antineoplastic Combined Chemotherapy Protocols / therapeutic use
-
Bleomycin / administration & dosage
-
Carmustine / administration & dosage
-
Carmustine / adverse effects
-
Combined Modality Therapy
-
Cytarabine / administration & dosage
-
Cytarabine / adverse effects
-
Dacarbazine / administration & dosage
-
Dermatomycoses / drug therapy
-
Dermatomycoses / etiology*
-
Dermatomycoses / microbiology
-
Dexamethasone / administration & dosage
-
Dexamethasone / adverse effects
-
Doxorubicin / administration & dosage
-
Etoposide / administration & dosage
-
Etoposide / adverse effects
-
Folliculitis / drug therapy
-
Folliculitis / etiology*
-
Folliculitis / microbiology
-
Hodgkin Disease / complications*
-
Hodgkin Disease / drug therapy
-
Hodgkin Disease / radiotherapy
-
Humans
-
Itraconazole / therapeutic use
-
Malassezia / isolation & purification*
-
Male
-
Melphalan / administration & dosage
-
Melphalan / adverse effects
-
Opportunistic Infections / drug therapy
-
Opportunistic Infections / etiology*
-
Opportunistic Infections / microbiology
-
Vinblastine / administration & dosage
Substances
-
Antifungal Agents
-
Cytarabine
-
Bleomycin
-
Itraconazole
-
Vinblastine
-
Etoposide
-
Dacarbazine
-
Dexamethasone
-
Doxorubicin
-
Melphalan
-
Carmustine